Effects of in-feed clinoptilolite treatment on serum metabolic and antioxidative biomarkers and acute phase response in dairy cows during pregnancy and early …
The objective of this study was to evaluate the effects of in-feed clinoptilolite (CPL) on serum
metabolic and antioxidative biomarkers, acute phase proteins and reproductive …
metabolic and antioxidative biomarkers, acute phase proteins and reproductive …
Chronic wounds as a public health problem
M ŠITUM, M Kolić, G REDŽEPI, S Antolić - Acta medica Croatica …, 2014 - hrcak.srce.hr
Chronic wounds represent a significant burden to patients; health care professionals and
the entire health care system. Regarding the healing process; wounds can be classified as …
the entire health care system. Regarding the healing process; wounds can be classified as …
[HTML][HTML] Successful treatment of autoimmune pulmonary alveolar proteinosis in a pediatric patient
M Turkalj, M Perica, Ž Ferenčić, D Erceg… - The American journal …, 2016 - ncbi.nlm.nih.gov
Objective: Rare disease Background: Pulmonary alveolar proteinosis (PAP) is a rare condition
characterized by the intra-alveolar accumulation of surfactant-derived material, which …
characterized by the intra-alveolar accumulation of surfactant-derived material, which …
Kronične rane kao javnozdravstveni problem.
M ŠITUM, M KOLIĆ, G REDŽEPI… - Acta Medica …, 2014 - search.ebscohost.com
Kronične rane su ogroman teret bolesnicima, medicinskom osoblju ali i cjelokupnom
zdravstvenom sustavu. Kronične rane su rane koje ne zarastaju unutar predviđenog razdoblja u …
zdravstvenom sustavu. Kronične rane su rane koje ne zarastaju unutar predviđenog razdoblja u …
[PDF][PDF] Recombinant factor VIIa in massive haemoptysis associated with chronic necrotising aspergillosis
M Samardžija, D Srdić, G Redžepi, S Pleština… - Collegium …, 2008 - hrcak.srce.hr
… Miroslav Samar`ija1, Dra`ena Srdi}1, Gzim Red`epi1, Sanja Ple{tina1, Ivica Ma`urani}2,
Marko Jakopovi}1 and Neven Miculini}1 …
Marko Jakopovi}1 and Neven Miculini}1 …
Adaptation and validation of the Cambridge pulmonary hypertension outcome review (CAMPHOR) for Croatia
…, M Jakopović, A Vukić Dugac, G Redžepi… - Acta Clinica …, 2019 - hrcak.srce.hr
Pulmonary hypertension (PH) is a chronic disease which severely impairs quality of life (QoL).
The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) is the first …
The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) is the first …
Overview and management of different post-COVID conditions
…, Ž Petelin Gadže, D Radić Krišto, G Redžepi… - … akademije znanosti i …, 2022 - hrcak.srce.hr
Coronavirus disease 2019 (COVID-19) pandemic resulted in global healthcare crises and
strained health resources, both in the acute and chronic phase of the disease. Similarly to post…
strained health resources, both in the acute and chronic phase of the disease. Similarly to post…
Gemcitabine in the first and second-line chemotherapy of advanced non-small cell lung cancer
…, D Baričević, M Jakopović, G Redžepi - Collegium …, 2005 - hrcak.srce.hr
Aim of this study was to estimate efficacy of gemcitabine in first and the second-line
chemotherapy for patients with advanced non-small cell lung cancer (stage III and IV). In first-line …
chemotherapy for patients with advanced non-small cell lung cancer (stage III and IV). In first-line …
Efficacy and Safety of Budesonide/Formeterol Combination Therapy in Asthma Patients
M Jakopović, F Pavičić, G Redžepi, S Pleština… - Collegium …, 2009 - hrcak.srce.hr
Budesonide/formoterol as single inhaler was developed for treating asthma patients who are
not adequately controlled on glucocorticoides alone. The aim of this study was to evaluate …
not adequately controlled on glucocorticoides alone. The aim of this study was to evaluate …
Safety and efficacy of erlotinib in patients with squamous cell lung cancer
Background:Erlotinib is epidermal growth factor receptor (EGFR) tyrosine-kinase inhibitor
which showed efficacy and tolerability in patients with advanced non-small cell lung cancer(…
which showed efficacy and tolerability in patients with advanced non-small cell lung cancer(…